Opioid Use After Thyroid and Parathyroid Surgeries
Not Applicable
Completed
- Conditions
- ThyroidectomyOpioid UseParathyroidectomyPain, Postoperative
- Interventions
- Other: Quality improvement bundle
- First Posted Date
- 2021-07-08
- Last Posted Date
- 2023-09-05
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 240
- Registration Number
- NCT04955444
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy
Phase 1
Suspended
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- Combination Product: Atezolizumab and Interleukin-12 Gene Therapy
- First Posted Date
- 2021-06-02
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 13
- Registration Number
- NCT04911166
- Locations
- 🇺🇸
Houston Methodist Cancer Center, Houston, Texas, United States
Mapping of the Human Brainstem During Continence and Micturition: Noninvasive 7-T fMRI Study
Active, not recruiting
- Conditions
- Healthy
- Interventions
- Diagnostic Test: Magnetic Resonance Imaging (MRI)Diagnostic Test: Post-Void ResidualDiagnostic Test: UroflowmetryBehavioral: Questionaire - AUA Symptom Score
- First Posted Date
- 2021-04-15
- Last Posted Date
- 2023-02-06
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 20
- Registration Number
- NCT04846387
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant
Phase 4
Withdrawn
- Conditions
- Acute Rejection of Renal TransplantDonor Specific AntibodiesKidney Disease, End-Stage
- Interventions
- First Posted Date
- 2020-12-11
- Last Posted Date
- 2020-12-11
- Lead Sponsor
- The Methodist Hospital Research Institute
- Registration Number
- NCT04665310
68 Ga-PSMA for High Risk Prostate Cancer
Phase 1
Completed
- Conditions
- Prostate CancerHigh Risk
- Interventions
- Drug: 68Ga-PSMA
- First Posted Date
- 2020-11-04
- Last Posted Date
- 2023-08-28
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 80
- Registration Number
- NCT04614363
- Locations
- 🇺🇸
Houston Methodist, Houston, Texas, United States
Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019)
Phase 1
- Conditions
- Covid19
- Interventions
- Biological: COVID 19 Convalescent Plasma
- First Posted Date
- 2020-09-18
- Last Posted Date
- 2020-11-02
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 350
- Registration Number
- NCT04554992
- Locations
- 🇺🇸
Houston Methodist Hopsital, Houston, Texas, United States
Blood Flow Restriction Training for The Shoulder
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- Device: Blood flow restriction therapy
- First Posted Date
- 2020-09-07
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 69
- Registration Number
- NCT04540367
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Motion Capture: Baseball Swing
Completed
- Conditions
- Elbow Force
- Interventions
- Behavioral: Motion capture participant
- First Posted Date
- 2020-08-06
- Last Posted Date
- 2020-08-27
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 16
- Registration Number
- NCT04503070
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Clazakizumab vs. Placebo - COVID-19 Infection
- First Posted Date
- 2020-07-31
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 60
- Registration Number
- NCT04494724
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Genetic Mechanism of Conserved Ancestral Haplotype in SCA10
- Conditions
- Spinocerebellar Ataxia Type 10
- Interventions
- Other: Non-interventional study
- First Posted Date
- 2020-07-31
- Last Posted Date
- 2021-09-01
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 100
- Registration Number
- NCT04495426
- Locations
- 🇧🇷
Universidade Federal do Paraná, Paraná, Curibita, Brazil
🇧🇷Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
🇺🇸Houston Methodist Hospital, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath